SPBC21C3.15c Antibody

What is the SPBC21C3.04c protein in S. pombe?

SPBC21C3.04c is identified as a probable 54S ribosomal protein L34, localized in the mitochondria of Schizosaccharomyces pombe. It is also referred to as L34mt or mitochondrial ribosomal protein subunit L34 (predicted). This protein plays a crucial role in the mitochondrial translation machinery of fission yeast, contributing to proper mitochondrial function and cellular respiration .

What types of antibodies are available for SPBC21C3.04c?

Current research primarily utilizes polyclonal antibodies for SPBC21C3.04c detection. Specifically, rabbit-derived polyclonal antibodies against Schizosaccharomyces pombe (strain 972/24843) SPBC21C3.04c have been developed and validated for research applications. These antibodies are typically purified using antigen-affinity methods to ensure specificity and minimal cross-reactivity .

What are the common applications for SPBC21C3.04c antibodies?

SPBC21C3.04c antibodies have been validated for several research applications, including:

• Western blot (WB) analysis for protein expression and size verification

• Enzyme-linked immunosorbent assay (ELISA) for quantitative detection

• Immunoprecipitation studies to investigate protein-protein interactions

• Chromatin immunoprecipitation experiments when studying DNA-protein interactions in the context of gene regulation and expression

What host systems are used to generate these antibodies?

The primary host system used for generating SPBC21C3.04c antibodies is rabbit, which produces IgG isotype immunoglobulins against the target protein. Rabbits are preferred due to their robust immune response against yeast proteins and the generally high affinity and specificity of rabbit-derived antibodies for research applications .

How should I design experiments to study mitochondrial protein interactions using SPBC21C3.04c antibodies?

When designing experiments to study mitochondrial protein interactions using SPBC21C3.04c antibodies, consider implementing a multi-faceted approach:

• Initial verification: Confirm antibody specificity using western blot analysis on wild-type and SPBC21C3.04c knockout strains

• Mitochondrial isolation: Employ differential centrifugation with appropriate buffers to isolate intact mitochondria from S. pombe

• Co-immunoprecipitation: Use cross-linking agents appropriate for mitochondrial membranes (e.g., DSP or formaldehyde) before lysis

• Controls: Include both positive controls (known mitochondrial protein interactions) and negative controls (cytosolic proteins)

• Validation: Confirm interactions using reciprocal co-IPs with antibodies against interacting partners

• Functional analysis: Complement biochemical studies with genetic approaches such as synthetic genetic interactions

What are the critical controls needed when using SPBC21C3.04c antibodies in chromatin immunoprecipitation experiments?

When conducting chromatin immunoprecipitation experiments with SPBC21C3.04c antibodies, the following controls are essential:

• Input control: Analyze a portion of the chromatin preparation before immunoprecipitation to normalize enrichment

• No-antibody control: Perform mock IP without primary antibody to assess non-specific binding

• IgG control: Use non-specific IgG from the same species (rabbit) to determine background binding

• Positive control regions: Include primers for genomic regions known to be associated with mitochondrial proteins

• Negative control regions: Include primers for genomic regions not expected to bind mitochondrial proteins

• Specificity validation: If possible, use strains with tagged SPBC21C3.04c and perform parallel ChIP with antibodies against the tag

• Technical replicates: Perform at least three independent biological replicates to ensure reproducibility

How can I optimize antibody concentration for western blot analysis of SPBC21C3.04c?

Optimizing antibody concentration for western blot analysis of SPBC21C3.04c requires a systematic titration approach:

• Initial range testing: Test a broad range of primary antibody dilutions (e.g., 1:500, 1:1000, 1:2000, 1:5000) using identical protein samples

• Blocking optimization: Test different blocking agents (BSA, non-fat milk, commercial blockers) to minimize background

• Incubation conditions: Compare different incubation times (2h at room temperature vs. overnight at 4°C) and buffer compositions

• Signal development: Adjust exposure times based on signal intensity, avoiding saturation

• Quantitative assessment: Plot signal-to-noise ratio against antibody concentration to identify optimal working dilution

• Reproducibility testing: Validate optimal concentration across multiple protein preparations and gel types

• Batch-to-batch variation consideration: Store records of optimal conditions for each antibody lot

How can SPBC21C3.04c antibodies be used to investigate mitochondrial stress responses in S. pombe?

To investigate mitochondrial stress responses using SPBC21C3.04c antibodies:

• Stress induction protocols:

  • Apply oxidative stress agents (e.g., H₂O₂, paraquat)

  • Use respiratory chain inhibitors (e.g., antimycin A, oligomycin)

  • Employ mitochondrial protein translation inhibitors (e.g., chloramphenicol)

• Time-course analysis:

  • Collect samples at multiple time points after stress induction

  • Monitor SPBC21C3.04c protein levels by western blot

  • Track subcellular localization changes using fractionation followed by immunoblotting

• Comparative analysis:

  • Compare wild-type responses with mitochondrial stress response mutants

  • Analyze co-regulation with other mitochondrial proteins

• Functional correlations:

  • Measure mitochondrial membrane potential in parallel

  • Assess mitochondrial morphology changes

  • Quantify reactive oxygen species production

• Integration with transcriptomic and proteomic data:

  • Correlate protein level changes with gene expression

  • Identify post-transcriptional regulatory mechanisms

What approaches can resolve contradictory results when using SPBC21C3.04c antibodies in different experimental contexts?

When facing contradictory results with SPBC21C3.04c antibodies across different experimental contexts:

• Antibody validation reassessment:

  • Verify specificity using knockout controls

  • Test multiple lots of antibodies

  • Compare polyclonal sources or epitopes

• Technical parameter evaluation:

  • Systematically vary buffer conditions

  • Adjust detergent types and concentrations

  • Modify fixation and extraction protocols

• Biological context considerations:

  • Evaluate cell cycle stage influences

  • Assess impact of growth conditions

  • Consider strain background effects

• Complementary methodologies:

  • Implement epitope tagging approaches

  • Use orthogonal detection methods

  • Apply proximity labeling techniques

• Quantitative analysis refinement:

  • Employ internal loading controls

  • Use spike-in standards

  • Apply statistical methods appropriate for the experimental design

How can I use SPBC21C3.04c antibodies in conjunction with RNA-binding protein studies?

To effectively combine SPBC21C3.04c antibody use with RNA-binding protein studies:

• RNA-protein complex isolation:

  • Perform RNA immunoprecipitation using SPBC21C3.04c antibodies

  • Apply appropriate cross-linking methods (UV or chemical)

  • Include RNase controls to distinguish direct vs. indirect interactions

• Sequential immunoprecipitation strategies:

  • First immunoprecipitate with SPBC21C3.04c antibodies

  • Elute under mild conditions

  • Perform second immunoprecipitation with antibodies against RNA-binding proteins

• RNA target identification:

  • Isolate and sequence RNAs associated with immunoprecipitated complexes

  • Compare RNA profiles between normal and stress conditions

  • Validate specific RNA targets using in vitro binding assays

• Functional correlation studies:

  • Assess the impact of RNA-binding protein mutations on SPBC21C3.04c localization

  • Evaluate the effects of mitochondrial stress on RNA-protein interactions

  • Analyze translation efficiency of target mRNAs in various conditions

What strategies can overcome low signal-to-noise ratios when using SPBC21C3.04c antibodies in immunofluorescence?

To improve signal-to-noise ratios in immunofluorescence with SPBC21C3.04c antibodies:

• Sample preparation optimization:

  • Test multiple fixation methods (formaldehyde, methanol, or combinations)

  • Optimize permeabilization (varying detergent types and concentrations)

  • Implement epitope retrieval techniques if necessary

• Blocking enhancements:

  • Extend blocking time (1-2 hours or overnight)

  • Test alternative blocking agents (fish gelatin, casein, commercial blockers)

  • Add detergents to reduce hydrophobic interactions

• Antibody incubation refinements:

  • Increase antibody dilution (test series from 1:100 to 1:2000)

  • Extend washing steps (more washes and longer duration)

  • Try signal amplification systems (tyramide or rolling circle amplification)

• Microscopy techniques:

  • Apply deconvolution algorithms

  • Use confocal microscopy to reduce out-of-focus light

  • Implement structured illumination for enhanced resolution

• Controls and validation:

  • Include absorption controls (pre-incubate antibody with excess antigen)

  • Compare with GFP-tagged protein localization patterns

  • Use CRISPR knockout cells as negative controls

How can I validate the specificity of SPBC21C3.04c antibodies for mitochondrial proteins?

To thoroughly validate SPBC21C3.04c antibody specificity for mitochondrial proteins:

• Genetic validation approaches:

  • Test reactivity in SPBC21C3.04c deletion strains

  • Compare signal in wild-type vs. gene-tagged strains

  • Assess cross-reactivity in overexpression systems

• Biochemical validation methods:

  • Perform peptide competition assays

  • Compare reactivity against recombinant protein

  • Use epitope mapping to confirm binding sites

• Subcellular fractionation analysis:

  • Isolate highly purified mitochondria

  • Compare signals across multiple cellular fractions

  • Include markers for different mitochondrial compartments

• Cross-species validation:

  • Test reactivity against homologous proteins in related species

  • Compare conservation of epitope sequences

  • Assess performance in different yeast strains

• Mass spectrometry verification:

  • Analyze immunoprecipitated protein by mass spectrometry

  • Confirm protein identity in enriched mitochondrial fractions

  • Quantify specificity by comparing IP results with proteome databases

What is the recommended protocol for using SPBC21C3.04c antibodies in chromatin-association studies?

For optimal results when using SPBC21C3.04c antibodies in chromatin-association studies:

• Cell preparation:

  • Culture S. pombe cells to mid-log phase (OD₆₀₀ = 0.5-0.7)

  • Apply appropriate stress conditions if studying stress responses

  • Cross-link with 1% formaldehyde for 15 minutes at room temperature

• Cell lysis and chromatin preparation:

  • Break cells using glass beads in appropriate lysis buffer

  • Sonicate to fragment chromatin (optimize conditions to achieve 200-500bp fragments)

  • Clarify lysate by centrifugation (14,000g for 15 minutes)

• Immunoprecipitation procedure:

  • Pre-clear lysate with protein A/G beads

  • Incubate with SPBC21C3.04c antibody at 4°C overnight (typically 2-5μg per reaction)

  • Capture complexes with fresh protein A/G beads

• Washing and elution:

  • Perform stringent washes with increasing salt concentrations

  • Elute complexes with SDS buffer at 65°C

  • Reverse cross-links by extended incubation at 65°C

• Analysis methods:

  • Analyze by western blot for protein interactions

  • Perform qPCR for DNA association

  • Use next-generation sequencing for genome-wide binding profiles

• Data interpretation:

  • Calculate enrichment relative to input and IgG controls

  • Apply appropriate statistical analyses

  • Validate findings with orthogonal approaches

How can I integrate SPBC21C3.04c antibody data with RNA-seq datasets?

To effectively integrate SPBC21C3.04c antibody data with RNA-seq datasets:

• Experimental design considerations:

  • Ensure matching experimental conditions between protein and RNA studies

  • Include appropriate time points to capture dynamic processes

  • Prepare biological replicates for statistical robustness

• Data normalization approaches:

  • Normalize western blot data using appropriate housekeeping controls

  • Apply standard RNA-seq normalization methods (RPKM, TPM, or DESeq2)

  • Consider batch effect correction if experiments were performed separately

• Correlation analysis methods:

  • Calculate Pearson or Spearman correlation between protein levels and transcript abundance

  • Perform time-lagged correlation to identify delayed effects

  • Cluster genes with similar protein-RNA relationships

• Pathway and network integration:

  • Map data to known mitochondrial pathways

  • Identify co-regulated gene modules

  • Apply network analysis to discover functional relationships

• Validation strategies:

  • Confirm key findings with targeted experiments

  • Use perturbation studies to test causal relationships

  • Apply mathematical modeling to predict system behavior

What statistical approaches are most appropriate for analyzing quantitative western blot data from SPBC21C3.04c antibody experiments?

For robust statistical analysis of quantitative western blot data using SPBC21C3.04c antibodies:

• Data preparation:

  • Normalize band intensities to loading controls

  • Log-transform data if necessary to achieve normal distribution

  • Calculate relative expression ratios compared to control conditions

• Statistical testing framework:

  • For two-group comparisons: Student's t-test or Mann-Whitney U test

  • For multiple group comparisons: ANOVA with appropriate post-hoc tests

  • For time-course experiments: repeated measures ANOVA or mixed models

• Sample size and power considerations:

  • Perform at least three independent biological replicates

  • Consider technical replicates to assess measurement variation

  • Calculate effect sizes to determine minimal sample sizes needed

• Multiple testing corrections:

  • Apply Bonferroni correction for stringent control

  • Use Benjamini-Hochberg procedure to control false discovery rate

  • Consider family-wise error rate when performing multiple comparisons

• Reproducibility assessment:

  • Calculate coefficients of variation across replicates

  • Implement bootstrap or jackknife resampling for confidence intervals

  • Report standardized effect sizes alongside p-values

How can I determine if post-translational modifications affect SPBC21C3.04c antibody recognition?

To assess the impact of post-translational modifications on SPBC21C3.04c antibody recognition:

• Epitope analysis:

  • Review antibody epitope sequences for potential modification sites

  • Analyze the protein sequence for known modification motifs

  • Compare antibody performance across different epitope regions

• Modification-specific experiments:

  • Treat lysates with phosphatases to remove phosphorylation

  • Use deglycosylation enzymes if glycosylation is suspected

  • Apply proteases for limited digestion to identify protected regions

• Comparative antibody approach:

  • Test multiple antibodies recognizing different epitopes

  • Compare recognition patterns under various cellular conditions

  • Use modification-specific antibodies in parallel experiments

• Biochemical validation:

  • Perform 2D gel electrophoresis to separate modified forms

  • Apply mass spectrometry to identify specific modifications

  • Compare antibody reactivity before and after modification-inducing treatments

• Functional correlation:

  • Assess antibody reactivity during cell cycle phases

  • Compare patterns during stress responses

  • Evaluate changes in response to signaling pathway activation

What are the best strategies for using SPBC21C3.04c antibodies in super-resolution microscopy?

For optimal super-resolution microscopy using SPBC21C3.04c antibodies:

• Sample preparation optimization:

  • Minimize sample thickness (use optimal coverslip thickness)

  • Implement careful fixation to preserve fine structures

  • Use small F(ab) fragments instead of whole IgG for better resolution

• Fluorophore selection:

  • Choose photostable fluorophores with appropriate quantum yield

  • Select fluorophores with minimal spectral overlap if multiplexing

  • Consider photoswitchable dyes for STORM/PALM applications

• Imaging parameter optimization:

  • Adjust laser power to minimize photobleaching

  • Optimize pixel size to match resolution capabilities

  • Set appropriate time intervals for dynamic processes

• Technical considerations by method:

  • STED: Use depletion laser power titration for optimal resolution

  • STORM/PALM: Optimize activation/reporter dye ratios

  • SIM: Ensure high signal-to-noise for reliable reconstruction

• Controls and validation:

  • Include fiducial markers for drift correction

  • Perform replicate imaging under identical conditions

  • Validate findings with complementary techniques

How can I develop a multiplex assay combining SPBC21C3.04c antibodies with other mitochondrial markers?

To develop effective multiplex assays combining SPBC21C3.04c antibodies with other mitochondrial markers:

• Antibody compatibility assessment:

  • Select antibodies raised in different host species

  • Test cross-reactivity of secondary antibodies

  • Verify non-overlapping epitopes when using multiple rabbit antibodies

• Fluorophore selection strategy:

  • Choose fluorophores with minimal spectral overlap

  • Consider quantum yield and photostability differences

  • Test spectral unmixing capabilities if using similar fluorophores

• Sequential staining protocols:

  • Implement blocking steps between antibody applications

  • Consider tyramide signal amplification for weak signals

  • Use zenon labeling technology for same-species antibodies

• Validation methods:

  • Perform single-stain controls for each antibody

  • Include fluorescence minus one (FMO) controls

  • Verify colocalization with known markers

• Data acquisition optimization:

  • Adjust detector settings to balance signal across channels

  • Apply appropriate compensation for spectral overlap

  • Use sequential scanning to minimize crosstalk

• Analysis approaches:

  • Implement colocalization analysis with appropriate statistics

  • Apply object-based image analysis for quantification

  • Use machine learning for pattern recognition in complex datasets

What considerations are important when using SPBC21C3.04c antibodies for proximity ligation assays?

When implementing proximity ligation assays (PLA) with SPBC21C3.04c antibodies:

• Antibody pair selection:

  • Ensure antibodies recognize distinct, non-overlapping epitopes

  • Verify compatibility with PLA probes (species compatibility)

  • Test antibodies individually before combination

• Assay optimization:

  • Titrate antibody concentrations (typically more dilute than for standard IF)

  • Adjust incubation times for primary antibodies

  • Optimize proximity probe concentration and ligation conditions

• Controls:

  • Positive control: Use antibody pairs against known interacting proteins

  • Negative control: Omit one primary antibody

  • Biological negative: Use non-interacting protein pairs

  • Technical control: Vary distance between epitopes using protein constructs

• Signal interpretation:

  • Quantify dot number per cell rather than intensity

  • Analyze subcellular distribution of PLA signals

  • Compare signal patterns across different conditions

• Troubleshooting approaches:

  • For high background: Increase antibody dilution or blocking stringency

  • For weak signal: Extend incubation times or amplification steps

  • For non-specific signal: Implement additional washing steps

• Validation strategies:

  • Confirm interactions with traditional co-IP

  • Correlate with FRET or BiFC data

  • Verify functional relevance through genetic approaches